Global Endoscopic Closure Systems Market Size is valued at USD 514.5 Million in 2024 and is predicted to reach USD 929.9 Million by the year 2034 at a 6.2% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Endoscopic closure systems are likely to transform the industry because of their advantages over previously available methods. The rising global prevalence of gastrointestinal and stomach cancer is expected to impact the market significantly. As the elderly population grows, the market is likely to expand dramatically. Endoscopic surgery is becoming more popular because it employs advanced technology to access inside organs through small incisions, resulting in less discomfort and faster recovery than traditional surgical procedures. These key factors are expected to drive demand for endoscopic closure systems. Endoscopic closure devices are in great need due to increased diagnostic endoscopy treatments and surgery. The market is driven by rising GI illness prevalence and technical advancements to produce novel endoscopic closure techniques.
Furthermore, the growing number of diagnostic and therapeutic endoscopic operations, such as EMR, ESD, and full-thickness excision of subepithelial cancers, is driving demand for endoscopic closure systems. The market's expansion is hampered by a need for more qualified staff with experience performing endoscopic procedures.
The endoscopic closure systems market is segmented on the product, distributional channel and end-use. Based on product, the endoscopic closure systems market is divided into endoscopic clips/end clips (over-the-scope clips), overstitch endoscopic suturing systems, endoscopic vacuum-assisted closure systems and other products. The endoscopic closure systems market is segmented directly and indirectly based on the distributional channel. Based on end-use, the market is divided into hospitals, clinics and ambulatory surgery centers.
The endoscopic vacuum-assisted closure system segment is expected to hold a substantial share of the market during the forecast period. Endoscopic closure devices are in great demand due to increased diagnostic endoscopy treatments and surgery. The market is driven by rising GI illness prevalence and technical advancements to produce novel endoscopic closure techniques. Furthermore, the growing number of diagnostic and therapeutic endoscopic operations, such as EMR, ESD, and full-thickness excision of subepithelial cancers, is driving demand for endoscopic closure systems.
Hospitals grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the expected time. It is due to patients' increased product preference for chronic disease treatment. Furthermore, good infrastructure and reimbursement policies boost segment expansion. Moreover, hospitals execute a high number of surgeries and are regarded as the primary healthcare system in the majority of countries. Compared to other healthcare systems, hospitals perform the greatest number of surgeries, boosting segment growth.
The North American endoscopic closure systems market is expected to register the highest market share in revenue shortly. The increasing prevalence and incidences of chronic diseases, the growing geriatric population, the availability of reimbursement for endoscopic procedures, and the growing presence of prominent vendors will all contribute to the growth of the endoscopic closure devices market in North America over the forecast period. In addition, Asia Pacific is projected to grow rapidly in the global Endoscopic closure systems market. Rising gastrointestinal disease prevalence, increased government funding for healthcare expansion, and well-developed technologies are significant drivers of the sector. These countries contribute to the growth of the healthcare industry. Furthermore, increased cancer and gastrointestinal disorders patients in developed countries would quickly raise demand for new detection and treatment types, leading to increased economic growth.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 514.5 Million |
| Revenue Forecast In 2034 | USD 929.9 Million |
| Growth Rate CAGR | CAGR of 6.2 % from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Product, Distribution Channel, End-Use |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Coopersurgical, Inc. (The Cooper Companies Inc.), Steris, Apollo Endosurgery, Inc., Boston Scientific Corporation, Ovesco Endoscopy Ag, Abbott, Medtronic, Olympus Corporation, Teleflex Incorporated, B. Braun Melsungen Ag. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Product-
By Distribution Channel
By End-use
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.